Thursday, July 5 |
| 08:30 a.m. | Opening Daniel Louvard, France |
08:45 a.m. | Heterogeneity of immune cells and cancer antigens in cancer vaccines and immunotherapy: mouse models and translation to human clinical trials (EATI Honorary Lecture 2018) Jay A. Berzofsky, USA |
| 09:30 a.m. | Host-Microbiome interactions – reality or myth? Harry Sokol, France |
10:00 a.m. | Programming tissue residency to enhance immunity to infection and tumors Ananda W. Goldrath, USA |
| 10:30 a.m. | Coffee break |
11:00 a.m. | Immunotherapy of cancer: clinical experimentation Fabrice André, France |
11:30 a.m. | From initiation to treatment: microbial influences in carcinogenesis Christian Jobin, USA |
| 12:00 p.m. | Lunch break |
| 02:00 p.m. | Defining molecular identity of intratumoral T cells to design better cancer immunotherapies Sergio Abrignani, Italy |
02:30 p.m. | Molecular and epigenetic programs defining tumor-specific T cell dysfunction Andrea Schietenger, USA |
03:00 p.m. | Immune parameters for predicting patient outcome Christian Ottensmeier, UK |
03:30 p.m. | Coffee break |
04:00 p.m. | IL-18 drives immunosuppression in multiple myeloma Ludovic Martinet, France |
04:30 p.m. | Induction and transcriptional regulation of the “co-inhibitory” gene module in T cells Vijay Kuchroo, USA |
| 5:00 p.m. | Celebration party “20th Year Miltenyi Biotec France” |
Friday, July 6 |
09:15 a.m. | Welcome Laurence Zitvogel / Guido Kroemer / Hervé Fridman, France |
09:30 a.m. | The role of GM-CSF in graft-vs-host disease: uncoupling of GvHD and GvL immunity Burkhardt Becher, Switzerland |
10:00 a.m. | Myeloid cells contribution to tumor outcome Miriam Merad, USA |
10:30 a.m. | Coffee break |
11:00 a.m. | Genetic screens to identify immunotherapy targets Nicholas Haining, USA |
11:30 a.m. | Cancer evolution and immune escape: TRACERx Rachel Rosenthal, UK |
12:00 p.m. | Lunch break |
02:00 p.m. | Dynamics of epigenetic traits in triple-negative breast cancer Céline Vallot, France |
02:30 p.m. | Single-cell transcriptomic network inference as a new approach to better characterize autoinflammatory diseases Mickaël Ménager, France |
03:00 p.m. | Molecular basis of T cell exhaustion: insights for immunotherapy E. John Wherry, USA |
03:30 p.m. | Coffee break |
04:00 p.m. | Metabolic interventions for the immunoprophylaxis of breast cancer Guido Kroemer, France |
04:30 p.m. | Closing / Farewell Jean Magon, France |
User
Favorite list
Download PDF
Play video
